• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在基于人群的队列中,大多数具有路易体病理的病例符合 Braak 进展模式,但“不符合”高度依赖于所应用的分期系统。

Most cases with Lewy pathology in a population-based cohort adhere to the Braak progression pattern but 'failure to fit' is highly dependent on staging system applied.

机构信息

Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.

Veterans Affairs Pacific Islands Health Care System, Honolulu, HI, USA; Departments of Medicine and John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA; The John A Hartford Foundation Center of Excellence in Geriatrics, Department of Geriatric Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA.

出版信息

Parkinsonism Relat Disord. 2019 Jul;64:124-131. doi: 10.1016/j.parkreldis.2019.03.023. Epub 2019 Mar 28.

DOI:10.1016/j.parkreldis.2019.03.023
PMID:30948243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6739131/
Abstract

Braak et al.'s 2003 paper detailing the caudo-rostral progression of Lewy body pathology (LP) formed the foundation of current understanding of disease spread in Parkinson's disease (PD); however, its methods are difficult to recreate and consequently multiple new staging systems emerged to recapitulate Braak's staging system using standard neuropathological methods and to account for other patterns of LP. Studies using these systems have documented widely variable rates of cases that 'fail to fit' expected patterns of LP spread. This could be due to population differences, features of individual systems, or may constitute under-recognized patterns of disease. We examined 324 neuropathological cases from the Honolulu Asia Aging Study and applied four different LP staging systems to determine the proportion of cases adhering to different staging methodologies and those that 'fail to fit' expected patterns of LP. Of 141 cases with LP (24: PD, 8: Dementia with Lewy bodies (DLB), 109: Incidental Lewy body disease (ILBD)), our application of Braak et al., 2003 classified 83.7%, Müller et al., 2005 classified 87.9%, Beach et al., 2009 classified 100%, and Leverenz et al., 2008 classified 98.6%. There were significant differences in the cases classifiable by the Leverenz and Beach systems versus the Braak and Müller systems (p < 0.001 for each). In this population-based autopsy cohort with a high prevalence of ILBD, the majority of cases were consistent with the progression characterized by the Braak et al. however, the determination of cases as atypical is highly dependent on the staging system applied.

摘要

布拉克等人 2003 年的论文详细描述了路易体病理学(LP)的头尾进展,为当前对帕金森病(PD)疾病传播的理解奠定了基础;然而,其方法难以重现,因此出现了多个新的分期系统,以使用标准神经病理学方法重现布拉克的分期系统,并解释 LP 的其他模式。使用这些系统的研究记录了广泛变化的病例未能符合 LP 传播预期模式的比率。这可能是由于人群差异、个别系统的特征,或者可能构成未被认识到的疾病模式。我们检查了来自檀香山亚洲老龄化研究的 324 例神经病理学病例,并应用了四种不同的 LP 分期系统,以确定符合不同分期方法的病例比例和那些未能符合 LP 预期模式的病例比例。在 141 例具有 LP 的病例中(24 例 PD、8 例路易体痴呆(DLB)、109 例意外路易体病(ILBD)),我们应用布拉克等人的方法,2003 年分类 83.7%、穆勒等人的 2005 年分类 87.9%、比奇等人的 2009 年分类 100%、莱文泽等人的 2008 年分类 98.6%。莱文泽和比奇系统与布拉克和穆勒系统可分类的病例存在显著差异(p 值均<0.001)。在这个基于人群的尸检队列中,ILBD 的患病率很高,大多数病例与布拉克等人描述的进展一致,然而,病例被判定为非典型的情况高度依赖于应用的分期系统。

相似文献

1
Most cases with Lewy pathology in a population-based cohort adhere to the Braak progression pattern but 'failure to fit' is highly dependent on staging system applied.在基于人群的队列中,大多数具有路易体病理的病例符合 Braak 进展模式,但“不符合”高度依赖于所应用的分期系统。
Parkinsonism Relat Disord. 2019 Jul;64:124-131. doi: 10.1016/j.parkreldis.2019.03.023. Epub 2019 Mar 28.
2
Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study.用于评估尸检大脑中 Lewy 病理的神经病理学共识标准:一项多中心研究。
Acta Neuropathol. 2021 Feb;141(2):159-172. doi: 10.1007/s00401-020-02255-2. Epub 2021 Jan 5.
3
Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies?偶然发现的路易体病:一些病例是否代表了路易体痴呆的临床前期?
Neurobiol Aging. 2011 May;32(5):857-63. doi: 10.1016/j.neurobiolaging.2009.05.019. Epub 2009 Jun 26.
4
A critical reappraisal of current staging of Lewy-related pathology in human brain.对人类大脑中路易体相关病理学当前分期的批判性重新评估。
Acta Neuropathol. 2008 Jul;116(1):1-16. doi: 10.1007/s00401-008-0406-y. Epub 2008 Jul 1.
5
Staging of Lewy-related pathology in dementia.痴呆中与路易体相关病理学的分期
Clin Neuropathol. 2012 Jul-Aug;31(4):216-23. doi: 10.5414/NP300471.
6
Lewy body-related alpha-synucleinopathy in the aged human brain.老年人大脑中与路易体相关的α-突触核蛋白病。
J Neural Transm (Vienna). 2004 Oct;111(10-11):1219-35. doi: 10.1007/s00702-004-0138-7. Epub 2004 Apr 2.
7
Is Braak staging valid for all types of Parkinson's disease?Braak 分期对于所有类型的帕金森病都有效吗?
J Neural Transm (Vienna). 2019 Apr;126(4):423-431. doi: 10.1007/s00702-018-1898-9. Epub 2018 Jun 25.
8
A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders.对路易体疾病中α-突触核蛋白病理学当前分期的批判性评估。
Biochim Biophys Acta. 2009 Jul;1792(7):730-40. doi: 10.1016/j.bbadis.2008.07.006. Epub 2008 Aug 5.
9
Neuropathological correlates of parkinsonian disorders in a large Dutch autopsy series.帕金森病在荷兰大型尸检系列中的神经病理学相关性。
Acta Neuropathol Commun. 2020 Mar 26;8(1):39. doi: 10.1186/s40478-020-00914-9.
10
Dementia with Lewy bodies: reclassification of pathological subtypes and boundary with Parkinson's disease or Alzheimer's disease.路易体痴呆:病理亚型的重新分类以及与帕金森病或阿尔茨海默病的界限
Neuropathology. 2004 Mar;24(1):72-8. doi: 10.1111/j.1440-1789.2003.00530.x.

引用本文的文献

1
A high-fidelity microfluidic platform reveals retrograde propagation as the main mechanism of α-Synuclein spread in human neurons.一个高保真微流控平台揭示了逆向传播是α-突触核蛋白在人类神经元中传播的主要机制。
NPJ Parkinsons Dis. 2025 Apr 20;11(1):80. doi: 10.1038/s41531-025-00936-x.
2
Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology.疾病进展建模揭示了路易体型 α-突触核蛋白病理轨迹的异质性。
Nat Commun. 2024 Jun 15;15(1):5133. doi: 10.1038/s41467-024-49402-x.
3
Skin nerve phosphorylated α-synuclein in the elderly.

本文引用的文献

1
Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.路易体病中 tau 病理学的认知和病理影响。
Ann Neurol. 2019 Feb;85(2):259-271. doi: 10.1002/ana.25392. Epub 2019 Jan 7.
2
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.路易体痴呆的诊断与管理:DLB联盟第四次共识报告
Neurology. 2017 Jul 4;89(1):88-100. doi: 10.1212/WNL.0000000000004058. Epub 2017 Jun 7.
3
Population-based analysis of pathological correlates of dementia in the oldest old.基于人群的高龄老年人痴呆病理相关性分析。
老年人皮肤神经中的磷酸化 α-突触核蛋白。
J Neuropathol Exp Neurol. 2024 Mar 20;83(4):245-250. doi: 10.1093/jnen/nlae015.
4
Estimating motor progression trajectory pursuant to temporal dynamic status of cardiac denervation in Parkinson's disease.根据帕金森病中心律失常的时间动态状态估计运动进展轨迹。
J Neurol. 2024 Apr;271(4):2019-2030. doi: 10.1007/s00415-023-12158-3. Epub 2024 Jan 6.
5
Shrinkage of olfactory amygdala connotes cognitive impairment in patients with Parkinson's disease.嗅觉杏仁核萎缩意味着帕金森病患者存在认知障碍。
Cogn Neurodyn. 2023 Oct;17(5):1309-1320. doi: 10.1007/s11571-022-09887-y. Epub 2022 Oct 20.
6
Fluid and Biopsy Based Biomarkers in Parkinson's Disease.基于液体和活检的帕金森病生物标志物。
Neurotherapeutics. 2023 Jul;20(4):932-954. doi: 10.1007/s13311-023-01379-z. Epub 2023 May 3.
7
Proposal for a Biologic Staging System of Parkinson's Disease.帕金森病的生物学分期系统提案。
J Parkinsons Dis. 2023;13(3):297-309. doi: 10.3233/JPD-225111.
8
Gastrointestinal involvement in Parkinson's disease: pathophysiology, diagnosis, and management.帕金森病的胃肠道受累:病理生理学、诊断与管理
NPJ Parkinsons Dis. 2022 Mar 24;8(1):31. doi: 10.1038/s41531-022-00295-x.
9
Prodromal and advanced non-motor features of Parkinson's disease.帕金森病的前驱期和晚期非运动特征。
BMJ Neurol Open. 2021 Jun 21;3(1):e000168. doi: 10.1136/bmjno-2021-000168. eCollection 2021.
10
An Update on Medical and Surgical Treatments of Parkinson's Disease.帕金森病的药物及手术治疗进展
Aging Dis. 2021 Jul 1;12(4):1021-1035. doi: 10.14336/AD.2020.1225. eCollection 2021 Jul.
Ann Clin Transl Neurol. 2017 Feb 12;4(3):154-165. doi: 10.1002/acn3.389. eCollection 2017 Mar.
4
Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.突触核蛋白病生存及痴呆症发病的神经病理学和遗传学关联:一项回顾性分析
Lancet Neurol. 2017 Jan;16(1):55-65. doi: 10.1016/S1474-4422(16)30291-5.
5
The significance of α-synuclein, amyloid-β and tau pathologies in Parkinson's disease progression and related dementia.α-突触核蛋白、淀粉样β和tau 蛋白病理学在帕金森病进展及相关痴呆中的意义。
Neurodegener Dis. 2014;13(2-3):154-6. doi: 10.1159/000354670. Epub 2013 Sep 11.
6
Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies.帕金森病痴呆:α-突触核蛋白、tau 和淀粉样β 病理学的汇聚。
Nat Rev Neurosci. 2013 Sep;14(9):626-36. doi: 10.1038/nrn3549. Epub 2013 Jul 31.
7
Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice.病理性α-突触核蛋白的传递会在非转基因小鼠中引发类似帕金森病的神经退行性变。
Science. 2012 Nov 16;338(6109):949-53. doi: 10.1126/science.1227157.
8
Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease.路易体病理不是帕金森病易损神经元退行性变的最初标志。
Neurology. 2012 Dec 11;79(24):2307-14. doi: 10.1212/WNL.0b013e318278fe32. Epub 2012 Nov 14.
9
Neuron-to-neuron transmission of α-synuclein fibrils through axonal transport.α-突触核蛋白纤维通过轴突运输在神经元间传递。
Ann Neurol. 2012 Oct;72(4):517-24. doi: 10.1002/ana.23747.
10
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach.美国国家老龄化研究所-阿尔茨海默病协会的阿尔茨海默病神经病理学评估指南:实用方法。
Acta Neuropathol. 2012 Jan;123(1):1-11. doi: 10.1007/s00401-011-0910-3. Epub 2011 Nov 20.